Measuring Adherence for antiretroviral therapy (ART) - The META Study

Much has been learned, including that the ‘Wisepill’ is the best tool to date to record adherence. With treatment readily available the greatest challenge for those working to end the HIV epidemic is to ensure that individuals living with HIV remain on treatment.
— Principal Investigator, Assoc Professor Catherine Orrell

The DTHF team at the Gugulethu Research Offices (GRO) under the direction of local Principal Investigator, Assoc Professor Catherine Orrell, has been involved with this adherence study for the past three years.   The aim is to contribute to the work being undertaken on adherence to antiretroviral therapy (ART) to achieve an AIDS-free generation.     This is the most comprehensive study to have been undertaken to understand ART by stage of HIV infection in sub-Saharan Africa.  There were eleven sites, seven in Mbarara, Uganda and four within the Klipfontein sub-district of Cape Town.   The dissemination of findings to stakeholders took place at UCT on 30th January. Read more ...